Liposome-containing topical skin preparation
The formulation of a liposome-containing skin preparation with specific phospholipids and thickeners at a defined viscosity stabilizes pine bark extract, addressing denaturation issues and enhancing stability.
Patent Information
- Application Number
- JP2023116995
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-02
- Filing Date
- 2023-07-18
- Publication Date
- 2024-11-15
AI Technical Summary
Existing skin preparations face challenges in maintaining the stability of water-soluble active ingredients encapsulated in liposomes due to denaturation during storage, particularly those containing pine bark extract, which are prone to precipitation and browning.
A liposome-containing skin preparation is formulated with hydrogenated soybean phospholipids having an acid value of 5 mgKOH/g or more, a thickener, and a viscosity of 4 mPa·s or more, encapsulating pine bark extract, using components like carboxyvinyl polymer or xanthan gum to enhance stability.
The formulation effectively suppresses precipitation and browning of pine bark extract, ensuring excellent stability and usability of the skin preparation.
Smart Images

Figure 2024160909000001 
Figure 2024160909000002 
Figure 2024160909000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an external skin preparation containing liposomes encapsulating a pine bark extract. [Background technology]
[0002] Liposomes, which are lipid membrane structures composed of phospholipids, etc., are useful in cosmetics and skin external preparations because they can encapsulate active ingredients. Conventionally, attempts have been made to encapsulate water-soluble active ingredients that improve the skin barrier function in liposomes and incorporate them into skin cosmetics to increase transdermal absorption (Patent Documents 1 to 3).
[0003] On the other hand, active ingredients encapsulated in liposomes may be denatured during storage due to the influence of temperature, etc. In particular, water-soluble active ingredients held in the aqueous phase of liposomes are more likely to exhibit such a tendency than oil-soluble active ingredients held in the lipid membrane of liposomes. In liposome-containing cosmetics, it is not easy to prevent the denaturation of water-soluble active ingredients encapsulated in liposomes, and no method for doing so has been realized. [Prior art documents] [Patent documents]
[0004] [Patent Document 1] JP 2006-328026 A [Patent Document 2] JP 2008-094809 A [Patent Document 3] JP 2009-102257 A DISCLOSURE OF THEINVENTION [Problem to be solved by the invention]
[0005] The present invention has been made in consideration of the above-mentioned conventional technology, and has as its objective the provision of an external skin preparation which encapsulates pine bark extract as a water-soluble active ingredient in liposomes while maintaining excellent stability of the water-soluble active ingredient. [Means for solving the problem]
[0006] The applicant has conducted intensive research in light of the above problems and has discovered that, in an external skin preparation which contains hydrogenated soybean phospholipids having an acid value of 5 mgKOH / g or more and a thickener, and which contains liposomes encapsulating pine bark extract as a water-soluble active ingredient, by adjusting the viscosity to 4 mPa s or more, an external skin preparation which has excellent stability of the water-soluble active ingredient can be obtained, thereby completing the present invention.
[0007] The outline of the present invention is as follows. <1> A liposome-containing topical skin preparation characterized by containing (A) a pine bark extract, (B) a hydrogenated soybean phospholipid having an acid value of 5 mgKOH / g or more, and (C) a thickener, said liposome-containing topical skin preparation characterized by having a viscosity of 4 mPa s or more and encapsulating the pine bark extract within liposomes. <2> The liposome membrane contains (B) hydrogenated soybean phospholipid with an acid value of 5 mgKOH / g or more, <1> 2. The liposome-containing topical skin preparation according to claim 1 . <3> Further, (D) at least one selected from the group consisting of 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, cyclohexylglycerin, and hexylglycerin. <1> 2. The liposome-containing topical skin preparation according to claim 1 . <4> (C) Contains carboxyvinyl polymer and / or xanthan gum as a thickening agent <1> 2. The liposome-containing topical skin preparation according to claim 1 . <5> Viscosity is 150 mPa s or more <1> 2. The liposome-containing topical skin preparation according to claim 1 . Effect of the Invention
[0008] By increasing the viscosity of a topical skin preparation containing liposomes encapsulating pine bark extract as a water-soluble active ingredient to 4 mPa s or more, precipitation and browning of the pine bark extract can be suppressed, making it possible to obtain a liposome-containing topical skin preparation with excellent stability. BEST MODE FOR CARRYING OUT THEINVENTION
[0009] The liposome-containing external skin preparation of the present invention will be described below, but the present invention is not limited to the following embodiments.
[0010] <(A) Pine bark extract> The liposome-containing skin external preparation of the present invention is an essential component of pine bark extract. As the pine bark extract (hereinafter also referred to as "component A") in the present invention, the bark extract of plants belonging to the order Pinaceae, such as French maritime pine (Pinus Martima), larch, black pine, red pine, Japanese white pine, Korean pine, Japanese dwarf pine, Ryukyu pine, Japanese white pine, white pine, and Aneda in the Quebec region of Canada, is preferably used. Among them, the bark extract of French maritime pine (Pinus Martima) is preferred, and the pine bark extract (Flavangenol (registered trademark)) manufactured by Toyo Shinyaku is more preferred.
[0011] Examples of the extraction solvent used to obtain the pine bark extract include water, organic solvents, and water-containing organic solvents (water-containing alcohols such as water-containing ethanol). Examples of the organic solvent include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, butane, acetone, hexane, cyclohexane, propylene glycol, water-containing ethanol, water-containing propylene glycol, ethyl methyl ketone, glycerin, methyl acetate, ethyl acetate, diethyl ether, dichloromethane, edible oils and fats, 1,1,1,2-tetrafluoroethane, and 1,1,2-trichloroethene. These water and organic solvents may be used alone or in combination. It is preferable to use water as the extraction solvent. The temperature of the solvent during extraction is not limited as long as it is equal to or lower than the boiling point of the solvent used.
[0012] There is no limitation on the method for obtaining the pine bark extract, and examples thereof include a heating extraction method, a supercritical fluid extraction method, a liquid carbon dioxide batch method, a liquid carbon dioxide reflux method, and a supercritical carbon dioxide reflux method. A combination of a plurality of extraction methods may also be used. By combining a plurality of extraction methods, it is possible to obtain pine bark extracts with various compositions.
[0013] Supercritical fluid extraction is a method of extraction using a supercritical fluid, which is a fluid in a state exceeding the gas-liquid critical point (critical temperature, critical pressure) of a substance. Examples of supercritical fluids that can be used include carbon dioxide, ethylene, propane, and nitrous oxide (laughing gas), with carbon dioxide being preferred.
[0014] In the supercritical fluid extraction method, an extraction step of extracting a target component with a supercritical fluid and a separation step of separating the target component from the supercritical fluid are performed. In the separation step, any of extraction and separation by pressure change, extraction and separation by temperature change, and extraction and separation using an adsorbent or absorbent may be performed.
[0015] Alternatively, supercritical fluid extraction may be performed using the entrainer addition method. In this method, for example, ethanol, propanol, n-hexane, acetone, toluene, or other aliphatic lower alcohols, aliphatic hydrocarbons, aromatic hydrocarbons, or ketones are added to the extraction fluid at about 2 to 20 W / V %, and supercritical fluid extraction is performed using this fluid, which dramatically increases the solubility of the target extract, such as OPCs (oligomeric proanthocyanidins), catechins, etc., in the extraction solvent or enhances the separation selectivity, thereby providing an efficient method for obtaining a pine bark extract.
[0016] Supercritical fluid extraction has the advantages of being applicable to substances that change or decompose at high temperatures because it can be operated at relatively low temperatures, of not leaving any extracted fluid behind, and of being able to recycle the solvent, making it possible to omit steps such as desolvation, thus simplifying the process.
[0017] From the viewpoint of safety, it is preferable to purify the pine bark extract obtained by the above extraction using a column method or a batch method. Examples of the column method include purification methods using adsorptive carriers such as Diaion HP-20, Sephadex-LH20, and chitin.
[0018] The pine bark extract used in the present invention contains proanthocyanidins (hereinafter referred to as OPCs) as one of its main components. OPCs are a group of compounds consisting of condensation polymers with a degree of polymerization of 2 or more, whose constituent units are flavan-3-ol and / or flavan-3,4-diol.
[0019] The content of the bark extract in the present invention is not particularly limited, but because it exhibits excellent stability, it is preferably 0.0000001 to 3 mass%, more preferably 0.000001 to 2 mass%, and particularly preferably 0.00001 to 1 mass%, in the liposome-containing topical skin preparation of the present invention.
[0020] <(B) Hydrogenated soybean phospholipids with an acid value of 5 mg KOH / g or more> The liposome-containing external skin preparation of the present invention contains hydrogenated soybean phospholipids with an acid value of 5 mgKOH / g or more as an essential component. In the external skin preparation of the present invention, the liposomes formed to encapsulate the pine bark extract contain hydrogenated soybean phospholipids with an acid value of 5 mgKOH / g or more. The hydrogenated soybean phospholipids with an acid value of 5 mgKOH / g or more in the present invention (hereinafter also referred to as "component B") may be, for example, soybean-derived phospholipids hydrogenated by a conventional method. As such hydrogenated soybean phospholipids with an acid value of 5 mgKOH / g or more, commercially available products provided by various companies may be used.
[0021] For the preparation of liposomes, one type of hydrogenated soybean phospholipid with an acid value of 5 mgKOH / g or more may be used alone, or two or more types may be used in combination, or one or more types of hydrogenated phospholipid with an acid value of less than 5 mgKOH / g and one or more types of hydrogenated phospholipid with an acid value of 5 mgKOH / g or more may be combined to have an acid value of 5 mgKOH / g or more. The acid value of the hydrogenated soybean phospholipid shall be the value measured in accordance with "2021 Standards for Quasi-Drug Ingredients, General Testing Methods, Part 28. Acid Value Measurement Method".
[0022] The content of hydrogenated soybean phospholipids having an acid value of 5 mgKOH / g or more used in the liposome-containing topical skin preparation of the present invention is preferably 0.00001 to 6 mass%, more preferably 0.0001 to 5 mass%, and particularly preferably 0.001 to 4 mass%, in order to obtain more stable liposomes.
[0023] <(C) Thickener> The liposome-containing skin topical preparation of the present invention contains a thickener as an essential component. The thickener in the present invention (hereinafter also referred to as "component C") is not particularly limited, and may be selected from the group consisting of plant-based polymers such as gum arabic, gum tragacanth, galactan, guar gum, carob gum, karaya gum, gellan gum, and carrageenan; microbial polymers such as xanthan gum, dextran, succinoglucan, and pullulan; animal-based polymers such as collagen, casein, albumin, and gelatin; starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch; methylcellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, sodium cellulose sulfate, hydroxypropylcellulose, and sodium carboxymethylcellulose. Examples of the thickener include cellulose-based polymers such as sodium alginate and crystalline cellulose; alginic acid-based polymers such as sodium alginate and propylene glycol alginate; vinyl-based polymers such as polyvinyl alcohol, polyvinyl acetate, polyvinyl methyl ether, polyvinylpyrrolidone, copolymers of vinylpyrrolidone and vinyl acetate, and carboxyvinyl polymers; and acrylic polymers such as sodium polyacrylate, polyethyl acrylate, alkanolamine polyacrylate, copolymers of alkyl methacrylate and dimethylaminoethyl methacrylate, poly2-acrylamido-2-methylpropanesulfonic acid, and polymethacryloyloxytrimethylammonium. From the viewpoint of obtaining more stable liposomes, the thickener used in the liposome-containing skin external preparation of the present invention is preferably a microbial polymer or a vinyl polymer, and xanthan gum is more preferable as the microbial polymer, and carboxyvinyl polymer is more preferable as the vinyl polymer.
[0024] The content of the thickener used in the liposome-containing external skin preparation of the present invention is preferably 0.001 to 4% by mass, more preferably 0.01 to 2% by mass, and particularly preferably 0.1 to 1% by mass, from the viewpoint of obtaining more stable liposomes. However, when two or more types of thickeners are contained, the content is the total amount thereof.
[0025] <(D) Polyhydric alcohol> The present invention preferably contains a polyhydric alcohol in addition to the above components A to C. The polyhydric alcohol in the present invention (hereinafter also referred to as "component D") is not particularly limited, but examples thereof include 1,3-butanediol, 1,3-propanediol, 3-methyl-1,3-butanediol, propylene glycol, dipropylene glycol, polypropylene glycol, butylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, polyoxyethylene glycol, glycerin, cyclohexylglycerin, hexylglycerin, polyglycerin (e.g., diglycerin, tetraglycerin), xylitol, maltitol, pentaerythritol, sorbitol, and trehalose. Among these, dihydric or trihydric alcohols are preferred, and from the viewpoint of improving the stability of the liposome-containing topical skin preparation of the present invention, 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, cyclohexylglycerin and hexylglycerin are more preferred, with 1,2-pentanediol being the most preferred.
[0026] When the liposome-containing external skin preparation of the present invention contains a polyhydric alcohol, the content of the polyhydric alcohol is not particularly limited, but is preferably 0.1 to 50% by mass, more preferably 0.4 to 30% by mass, and particularly preferably 1 to 20% by mass. However, when two or more kinds of polyhydric alcohols are contained, the content is the total amount.
[0027] <Other ingredients> The liposome-containing skin topical preparation of the present invention may contain other components in addition to the above-mentioned components A to D. Examples of the other components include basic compounds (inorganic bases such as sodium hydroxide, potassium hydroxide, and ammonia; basic amino acids such as arginine, lysine, and histidine; amine compounds such as ethanolamine, diethanolamine, triethanolamine, 2-amino-2-methyl-1,3-propanediol (AMPD), and 2-amino-2-hydroxymethyl-1,3-propanediol (tromethamine)), and the like), acidic compounds (inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, and carbonic acid; acetic acid, formic acid, and the like), and the like. , propionic acid, butyric acid, citric acid, lactic acid, succinic acid, malic acid, tartaric acid, pyrrolidone carboxylic acid (PCA), gluconic acid, benzoic acid, ethylenediaminetetraacetic acid (EDTA) or its salts, etidronic acid, phytic acid, acidic amino acids and other organic acids, fat-soluble compounds (sterols such as phytosterol, cholesterol, di(phytosteryl / octyldodecyl) lauroyl glutamate, phytosteryl oleate, phytosteryl glucoside, etc.; γ-oryzanol, glycyrrhizic acid, ursolecithin, glyceryl stearate ... triterpenes such as oleic acid; fat-soluble vitamins such as retinol, hydrogenated retinol, cholecalciferol, tocopherol, and ascorbic acid esters; carotenoids such as astaxanthin and beta-carotene; coenzymes such as ubiquinone; hydrocarbons such as limonene, petrolatum, and squalane; ceramide EOS, ceramide NG (ceramide 2), ceramide NP (ceramide 3), ceramide AP (ceramide 6II), ceramide EOP (ceramide 1), dihydroxylignoceroyl phytosphingosine, celeb ceramides such as phospholipids, glycosphingolipids, cetyl PG hydroxyethyl palmitamide, etc.; fat-soluble polyphenols such as tetrahydrodiferuloylmethane, pterostilbene, etc.), oils, surfactants other than hydrogenated soybean phospholipids with an acid value of 5 mgKOH / g or more, moisturizers, whitening agents, coloring materials, alcohols, neutral amino acids, sugars, water-soluble vitamins, coloring agents, powders, UV absorbers, preservatives, antibacterial agents, antioxidants, fragrances, beauty ingredients, electrolytes, fibers, plant extracts other than pine bark extract, water, etc. These may be used alone or in combination of two or more.
[0028] The form of the liposome-containing skin external preparation of the present invention is not particularly limited and can be any form.Specific forms include, for example, basic cosmetics such as lotion, beauty essence, milky lotion, cream, ointment, lotion, oil, gel, pack, etc.; skin cleansing products such as soap, body soap, cleansing cream, cleansing lotion, cleansing milk, face wash, etc.; hair washing cosmetics such as shampoo, rinse, treatment, etc.; hair styling products such as hair cream, hair spray, hair tonic, hair gel, hair lotion, hair oil, hair essence, hair water, hair wax, hair foam, etc., hair growth and hair care products, one-component hair dyes and two-component dyes, etc. Examples of the cosmetic products include hair dyes such as hair tonics and hair colorings, perm agents such as permanent wave agents and hair straighteners, and wave-maintaining agents; makeup cosmetics such as foundations, face powders, face powders, lipsticks, blushers, eye shadows, eyeliners, mascaras, eyebrow pencils, eyelashes, and the like; finishing cosmetics such as nail beautifiers; perfumes, bath products, and others, anti-inflammatory agents, anti-armpit odor agents, hair cosmetics for preventing dandruff or itching, hair loss inhibitors, hair removers, shaving agents, sunscreens, acne prevention or improvement agents, cosmetics for oily skin, sanitary products, sanitary cotton, wet tissues, etc. Among these dosage forms, basic cosmetics such as lotions, beauty essences, milky lotions, creams, ointments, lotions, oils, gels, and packs are preferred from the viewpoint of particularly exerting the effects of the present invention.
[0029] <Viscosity> The viscosity of the liposome-containing external skin preparation of the present invention at 20° C. is preferably 4 mPa·s or more, more preferably 150 mPa·s or more, and particularly preferably 300 mPa·s or more, in order to exhibit excellent stability. From the viewpoint of usability, the viscosity at 20° C. is 60,000 mPa·s or less, more preferably 50,000 mPa·s or less, and particularly preferably 40,000 mPa·s or less. The viscosity can be measured with a B-type viscometer.
[0030] <ph> The pH of the liposome-containing external skin preparation of the present invention is preferably 3.0 to 8.0, more preferably 3.5 to 7.0, and particularly preferably 4.0 to 6.5, in order to exhibit excellent stability.
[0031] The present invention also provides a method for producing a liposome-containing external skin preparation, which comprises mixing the above-mentioned components A, B, and C (mixing step). In this method, in addition to the above-mentioned components A to C, component D and the components described in the above section <Other components> may be further mixed. The preferred embodiments of each component are as described above.
[0032] In this production method, the mixing temperature is not particularly limited, but is preferably 25 to 120° C., more preferably 40 to 100° C., and even more preferably 60 to 90° C. The mixing time is also not particularly limited, but is preferably 10 to 60 minutes. The mixing method is not particularly limited, but since it does not require a high level of mechanical shearing force, it can be carried out using known mixing means such as a magnetic stirrer (e.g., a hot stirrer), a paddle mixer, a propeller mixer, or a planetary mixer.
[0033] In this production method, in addition to the above mixing step, other steps such as purification (for example, filtration, etc.), cooling, heating, storage, etc. may be appropriately carried out. EXAMPLES
[0034] The present invention will be described in more detail below with reference to examples, although the present invention is not limited to these examples.
[0035] <Preparation of liposome-containing topical skin preparation> A liposome-containing skin external preparation was prepared by the following method. A liposome-forming composition containing hydrogenated soybean phospholipid with an acid value of 5 mgKOH / g or more, 1,2-pentanediol, phytosterol, and purified water was placed in a 100 mL beaker, and stirred at 80°C for 20 minutes using a hot stirrer. Next, according to the blending amounts in Tables 1 to 3, purified water, pine bark extract, and a thickener (carboxyvinyl polymer or xanthan gum) previously prepared as a 2% aqueous solution were placed in another 100 mL beaker and stirred at 200 rpm to prepare an aqueous phase. In Comparative Examples 1, 2, and 7, an aqueous phase was prepared without adding a thickener. The aqueous phase was heated to 80°C, and 1 mL of the liposome-forming composition previously heated to 80°C was added to 99 mL of the aqueous phase while stirring at 100 rpm to obtain an external skin preparation containing liposomes encapsulating pine bark extract. Comparative Examples 5 and 6, which did not use a liposome-forming composition, were prepared by adding purified water, pine bark extract, and a thickener (carboxyvinyl polymer or xanthan gum) previously prepared as a 2% aqueous solution to a 200 mL beaker and stirring at 200 rpm. For the pine bark extract, a hot water extract of French maritime pine bark (dried powder, "Flavangenol (registered trademark)", manufactured by Toyo Shinyaku Co., Ltd.) was used. The liposome-forming compositions and thickeners used together with the pine bark extract shown in Table 1 were commercially available products.
[0036] 2. Evaluation For each sample in Table 1, the following items were measured. <1> Precipitation: The obtained samples were stored at 5°C for 7 days. The samples immediately after preparation (day 0) and the samples on the 3rd and 7th days were visually inspected and scored according to the following criteria. The score on day 0 was subtracted from the score on each measurement day, and the difference was calculated to evaluate the precipitation inhibition effect. The closer the value is to 0, the higher the precipitation inhibition effect. (standard) 3 points: No precipitation observed 2 points: Precipitation is visible in some parts of the sample Score 1: Precipitation is visible throughout the sample <2> Browning: The obtained samples were stored at 40°C for 7 days. Approximately 2.5 mL was gently removed with a pipette from each of the samples immediately after preparation (day 0) and on the 7th day, and the absorbance at a wavelength of 500 nm was measured with an ultraviolet-visible spectrophotometer (UV1800, Shimadzu Corporation). The absorbance on the 7th day was subtracted from the absorbance on the 0th day, and the difference (change value) was calculated to evaluate the browning inhibition effect. The smaller the difference, the higher the browning inhibition effect. <3> Viscosity: Measured using a digital Brookfield viscometer (DV1M) with a No. 2 spindle at 20° C. and a rotation speed of 5 rpm.
[0037] [Table 1]
[0038] The evaluation results obtained when the amount of pine bark extract was set to 0.001% are shown in Table 1. As is clear from the results shown in Table 1, it can be seen that Examples 1 and 2, in which the topical skin preparations containing liposomes encapsulating pine bark extract contain a carboxyvinyl polymer or xanthan gum as a thickener and have a viscosity of 8 mPa s or more, exhibit superior precipitation inhibition effects and browning inhibition effects compared to Comparative Example 1, which does not contain a thickener and has a viscosity of 0 mPa s. Furthermore, compared to Example 1, which contains a carboxyvinyl polymer as a thickener, Example 2, which contains xanthan gum as a thickener, exhibits superior precipitation inhibition effects even on the 7th day and also exhibits superior browning inhibition effects, indicating that a topical skin preparation with particularly excellent stability can be obtained when it contains xanthan gum as a thickener and has a viscosity of 440 mPa s or more.
[0039] [Table 2]
[0040] Table 2 shows the evaluation results obtained when the amount of pine bark extract was set to 0.01%. As is clear from the results shown in Table 2, the topical skin preparations containing liposomes encapsulating pine bark extract in Examples 3 and 4, which contain carboxyvinyl polymer or xanthan gum as a thickening agent and have a viscosity of 5 mPa s or more, show superior precipitation inhibition effects and browning inhibition effects compared to Comparative Example 2, which does not contain a thickening agent and has a viscosity of 0 mPa s. Furthermore, compared to Comparative Examples 3 and 4, in which the topical skin preparations containing liposomes encapsulating pine bark extract contain a carboxyvinyl polymer or xanthan gum as a thickening agent but have a viscosity of 0 mPa s, Examples 3 and 4 show excellent precipitation inhibitory effects and browning inhibitory effects, respectively. This shows that when the topical skin preparations containing liposomes encapsulating pine bark extract contain a carboxyvinyl polymer or xanthan gum as a thickening agent and have a viscosity of 5 mPa s or more, a topical skin preparation with excellent stability can be obtained. Furthermore, compared with Example 3, which contained a carboxyvinyl polymer as a thickener, Example 4, which contained xanthan gum as a thickener, showed an excellent precipitation inhibition effect even on the seventh day. From this result, it can be seen that when xanthan gum is contained as a thickener and the viscosity is 440 mPa s or more, a topical skin preparation with particularly excellent stability can be obtained. On the other hand, Comparative Example 5, which does not contain hydrogenated soybean phospholipids with an acid value of 5 mgKOH / g or more and therefore does not form liposomes, and which contains only pine bark extract and carboxyvinyl polymer as a thickener, has low precipitation inhibition effects and browning inhibition effects.Similarly, Comparative Example 6, which contains only pine bark extract and xanthan gum as a thickener, has a low browning inhibition effect, so it can be seen that the present invention is effective for pine bark extract encapsulated in liposomes.
[0041] [Table 3]
[0042] The evaluation results obtained when the amount of pine bark extract was set to 0.1% are shown in Table 3. As is clear from the results shown in Table 3, the topical skin preparations containing liposomes encapsulating pine bark extract in Examples 5 and 6, which contain carboxyvinyl polymer or xanthan gum as a thickening agent and have a viscosity of 6 mPa s or more, show superior precipitation inhibition effects and browning inhibition effects compared to Comparative Example 7, which does not contain a thickening agent and has a viscosity of 0 mPa s. Furthermore, compared with Example 5, which contained a carboxyvinyl polymer as a thickener, Example 6, which contained xanthan gum as a thickener, showed an excellent precipitation inhibition effect even on the 7th day, indicating that when xanthan gum is contained as a thickener and the viscosity is 498 mPa s or more, a topical skin preparation with particularly excellent stability can be obtained.
[0043] Based on the above, when a topical skin preparation containing liposomes encapsulating pine bark extract contains hydrogenated soybean phospholipids with an acid value of 5 mgKOH / g or more, and carboxyvinyl polymer or xanthan gum as a thickener, and has a viscosity of 5 mPa s or more, precipitation and browning of the pine bark extract encapsulated in the liposomes is suppressed, and excellent stability of the pine bark extract is achieved.
[0044] Various embodiments of the present invention will be described below as examples, but the technical scope of the present invention is not limited to these.
[0045] <Prescription Examples 1-4> A beauty essence was manufactured according to the formulation in Table 4 below. The resulting liposome-containing beauty essence had a viscosity of 15,000 to 35,000 mPa·s, was excellent in stability of the pine bark extract, and felt good when used.
[0046] [Table 4]
[0047] <Prescription Examples 5 and 6> An emulsion was manufactured according to the formulation in Table 5. The resulting liposome-containing emulsion had a viscosity of 100 to 50,000 mPa·s, was excellent in stability of the pine bark extract, and had a good feel when used.
[0048] [Table 5]
[0049] <Prescription Examples 7 and 8> A lotion was manufactured according to the formulation in Table 6. The resulting liposome-containing lotion had a viscosity of 500 to 1000 mPa·s, excellent stability of the pine bark extract, and a pleasant feel when used.
[0050] [Table 6]
[0051] <Prescription Examples 9 and 10> An all-in-one gel was manufactured according to the formulation in Table 5. The obtained liposome-containing all-in-one gel had a viscosity of 15,000 to 25,000 mPa·s, excellent stability of the pine bark extract, and a pleasant feel when used.
[0052] [Table 7] [Industrial Applicability]
[0053] According to the present invention, in a liposome-containing topical skin preparation containing liposomes encapsulating pine bark extract as a water-soluble active ingredient, a liposome-containing topical skin preparation with excellent stability can be obtained by including hydrogenated soybean phospholipids having an acid value of 5 mgKOH / g or more as the phospholipid and by setting the viscosity to 4 mPa s or more.< / ph>
Claims
1. A liposome-containing topical skin preparation characterized by containing (A) pine bark extract, (B) hydrogenated soybean phospholipid having an acid value of 5 mgKOH / g or more, and (C) a thickener, the liposome-containing topical skin preparation characterized by having a viscosity of 4 mPa·s or more and encapsulating the pine bark extract within the liposomes.
2. 2. The liposome-containing external skin preparation according to claim 1, further comprising (D) at least one selected from the group consisting of 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, cyclohexylglycerin, and hexylglycerin.
3. 2. The liposome-containing external skin preparation according to claim 1, further comprising (C) a carboxyvinyl polymer and / or xanthan gum as a thickening agent.
Citation Information
Patent Citations
Liposome and skin care preparation containing the same
JP2006328026A
Liposome composition and cosmetic compounded with the same, and external preparation for skin
JP2008094809A
Liposome and skin cosmetic comprising the same
JP2009102257A
Cited By
Scalp and hair improvement agent
WO2025258212A1
